Literature DB >> 14656711

Rapid translocation of hepatic glucokinase in response to intraduodenal glucose infusion and changes in plasma glucose and insulin in conscious rats.

Chang An Chu1, Yuka Fujimoto, Kayano Igawa, Joseph Grimsby, Joseph F Grippo, Mark A Magnuson, Alan D Cherrington, Masakazu Shiota.   

Abstract

The rate of liver glucokinase (GK) translocation from the nucleus to the cytoplasm in response to intraduodenal glucose infusion and the effect of physiological rises of plasma glucose and/or insulin on GK translocation were examined in 6-h-fasted conscious rats. Intraduodenal glucose infusion (28 mg.kg(-1).min(-1) after a priming dose at 500 mg/kg) elevated blood glucose levels (mg/dl) in the artery and portal vein from 90 +/- 3 and 87 +/- 3 to 154 +/- 4 and 185 +/- 4, respectively, at 10 min. At 120 min, the levels had decreased to 133 +/- 6 and 156 +/- 5, respectively. Plasma insulin levels (ng/ml) in the artery and the portal vein rose from 0.7 +/- 0.1 and 1.8 +/- 0.3 to 11.8 +/- 1.5 and 20.2 +/- 2.0 at 10 min, respectively, and 12.4 +/- 3.1 and 18.0 +/- 4.8 at 30 min, respectively. GK was rapidly exported from the nucleus as determined by measuring the ratio of the nuclear to the cytoplasmic immunofluorescence (N/C) of GK (2.9 +/- 0.3 at 0 min to 1.7 +/- 0.2 at 10 min, 1.5 +/- 0.1 at 20 min, 1.3 +/- 0.1 at 30 min, and 1.3 +/- 0.1 at 120 min). When plasma glucose (arterial; mg/dl) and insulin (arterial; ng/ml) levels were clamped for 30 min at 93 +/- 7 and 0.7 +/- 0.1, 81 +/- 5 and 8.9 +/- 1.3, 175 +/- 5 and 0.7 +/- 0.1, or 162 +/- 5 and 9.2 +/- 1.5, the N/C of GK was 3.0 +/- 0.5, 1.8 +/- 0.1, 1.5 +/- 0.1, and 1.2 +/- 0.1, respectively. The N/C of GK regulatory protein (GKRP) did not change in response to the intraduodenal glucose infusion or the rise in plasma glucose and/or insulin levels. The results suggest that GK but not GKRP translocates rapidly in a manner that corresponds with changes in the hepatic glucose balance in response to glucose ingestion in vivo. Additionally, the translocation of GK is induced by the postprandial rise in plasma glucose and insulin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14656711     DOI: 10.1152/ajpgi.00218.2003

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  27 in total

1.  Brought to life: targeted activation of enzyme function with small molecules.

Authors:  Anthony C Bishop; Vincent L Chen
Journal:  J Chem Biol       Date:  2008-09-20

2.  Time-dependent mechanisms in beta-cell glucose sensing.

Authors:  Thomas Vagn Korsgaard; Morten Colding-Jørgensen
Journal:  J Biol Phys       Date:  2006-11-09       Impact factor: 1.365

3.  Comparison of the physiological relevance of systemic vs. portal insulin delivery to evaluate whole body glucose flux during an insulin clamp.

Authors:  Tiffany D Farmer; Erin C Jenkins; Tracy P O'Brien; Gregory A McCoy; Allison E Havlik; Erik R Nass; Wendell E Nicholson; Richard L Printz; Masakazu Shiota
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-12-16       Impact factor: 4.310

4.  The role of CCK8 in the inhibition of glucose production.

Authors:  Christopher J Ramnanan; Dale S Edgerton; Alan D Cherrington
Journal:  Cellscience       Date:  2009-10-27

5.  Glucokinase regulatory protein (GCKR) gene rs4425043 polymorphism is associated with overweight and obesity in Chinese women.

Authors:  Feifei Cao; Xiaofeng Wang; Ming Lu; Yajun Yang; Yu An; Juan Zhang; Xingdong Chen; Lei Li; Shuyuan Li; Jie Jiang; Weimin Ye; Li Jin
Journal:  Lipids       Date:  2011-02-13       Impact factor: 1.880

6.  Evidence for heightened hexokinase II immunoexpression in hepatocyte dysplasia and hepatocellular carcinoma.

Authors:  Grace Guzman; Rohini Chennuri; Alexander Chan; Bryan Rea; Ada Quintana; Roshan Patel; Pei-Zhang Xu; Hui Xie; Nissim Hay
Journal:  Dig Dis Sci       Date:  2014-11-08       Impact factor: 3.199

7.  Glucotoxicity targets hepatic glucokinase in Zucker diabetic fatty rats, a model of type 2 diabetes associated with obesity.

Authors:  Kiichiro Ueta; Tracy P O'Brien; Gregory A McCoy; Kuikwon Kim; Erin C Healey; Tiffany D Farmer; E Patrick Donahue; Audree B Condren; Richard L Printz; Masakazu Shiota
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-04-08       Impact factor: 4.310

8.  Portal glucose delivery stimulates muscle but not liver protein metabolism.

Authors:  Guillaume Kraft; Katie C Coate; Dominique Dardevet; Ben Farmer; E Patrick Donahue; Phillip E Williams; Alan D Cherrington; Mary Courtney Moore
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-09-25       Impact factor: 4.310

9.  Lack of glucokinase regulatory protein expression may contribute to low glucokinase activity in feline liver.

Authors:  Erin K Hiskett; Orn-Usa Suwitheechon; Sara Lindbloom-Hawley; Daniel L Boyle; Thomas Schermerhorn
Journal:  Vet Res Commun       Date:  2008-09-09       Impact factor: 2.459

10.  Central nervous system neuropeptide Y signaling modulates VLDL triglyceride secretion.

Authors:  John M Stafford; Fang Yu; Richard Printz; Alyssa H Hasty; Larry L Swift; Kevin D Niswender
Journal:  Diabetes       Date:  2008-03-10       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.